Pfizer (PFE) PT Raised to $64 at Truist Securities; 'Incrementally more positive' following results
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Pfizer (NYSE: PFE) to $64.00 (from $62.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
